Temozolomide in the treatment of an invasive prolactinoma resistant to dopamine agonists

Author： Neff Lisa   Weil Michelle   Cole Alan   Hedges Thomas   Shucart William   Lawrence Donald   Zhu Jay-Jiguang   Tischler Arthur   Lechan Ronald  

Publisher： Springer Publishing Company

ISSN： 1386-341X

Source： Pituitary, Vol.10, Iss.1, 2007-03, pp. : 81-86

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatment of Pituitary Tumors: Dopamine Agonists

By Iván Gabriella   Szigeti-Csúcs Nikoletta   Oláh Márk   Nagy György M.   Góth Miklós I.  

Endocrine Journal, Vol. 28, Iss. 1, 2005-10 ,pp. : 101-110

Humana Press, Inc

Access to resources Recommend Favorite

Efficacy of the combined cabergoline and octreotide treatment in a case of a dopamine-agonist resistant macroprolactinoma

By Fusco Alessandra  

Pituitary, Vol. 14, Iss. 4, 2011-12 ,pp. : 351-357

Springer Publishing Company

Access to resources Recommend Favorite

Effect of dopamine agonists on lactotroph adenomas of the human pituitary

By Stefaneanu Lucia   Kovacs Kalman   Scheithauer Bernd   Kontogeorgos George   Riehle Darren   Sebo Thomas   Murray David   Vidal Sergio   Tran Ami   Buchfelder Michael   Fahlbusch Rudolf  

Endocrine Pathology, Vol. 11, Iss. 4, 2000-12 ,pp. : 341-352

Humana Press, Inc

Access to resources Recommend Favorite

Dopamine Agonists Induce Episodes of Irresistible Daytime Sleepiness

By  

European Neurology, Vol. 49, Iss. 1, 2002-12 ,pp. : 30-33

Karger

Access to resources Recommend Favorite

Pre-operative dopamine agonist therapy improves post-operative tumor control following prolactinoma resection

By Sughrue Michael   Chang Edward   Tyrell J.   Kunwar Sandeep   Wilson Charles   Blevins Lewis  

Pituitary, Vol. 12, Iss. 3, 2009-09 ,pp. : 158-164

Springer Publishing Company

Access to resources Recommend Favorite